NCT05256290
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05256290
Title Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Black Diamond Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of Alabama Birmingham Alabama 35294 United States Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
City of Hope Comprehensive Cancer Center (Duarte Campus) Duarte California 91010 United States Details
City of Hope Huntington Beach Huntington Beach California 92648 United States Details
City of Hope Orange County Lennar Foundation Cancer Center Irvine California 92618 United States Details
Cedars Sinai Medical Center Los Angeles California 90048 United States Details
Valkyrie Clinical Trials Los Angeles California 90067 United States Details
Rocky Mountain Cancer Center Lone Tree Colorado 80124 United States Details
Sibley Memorial Hospital Johns Hopkins Medicine Washington D.C. District of Columbia 20016 United States Details
Mayo Clinic- Jacksonville Jacksonville Florida 32224 United States Details
Miami Cancer Institute - Baptist Health South Florida Miami Florida 33176 United States Details
Orlando Health Cancer Institute Orlando Florida 32806 United States Details
Emory Winship Cancer Center Atlanta Georgia 30322 United States Details
UHP- University of Hawaii Cancer Center Honolulu Hawaii 96813 United States Details
Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago Illinois 60611 United States Details
Indiana University Indianapolis Indiana 46202 United States Details
University of Kansas Cancer Center Fairway Kansas 66205 United States Details
Johns Hopkins Bayview Medical Center Baltimore Maryland 21224 United States Details
The Center for Cancer and Blood Disorders Bethesda Maryland 20817 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02115 United States Details
Mayo Clinic- Rochester Rochester Minnesota 55905 United States Details
Siteman Cancer Center St Louis Missouri 63110 United States Details
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10021 United States Details
Columbia University Irving Medical Center New York New York 10032 United States Details
Montefiore Medical Center The Bronx New York 10461 United States Details
UNC Hospitals - Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27514 United States Details
Durham VA Medical Center Durham North Carolina 27705 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Ohio State Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Thomas Jefferson University/Sidney Kimmel Cancer Center Philadelphia Pennsylvania 19107 United States Details
University of Pittsburgh Medical Center - Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
The West Clinic PLLC, dba West Cancer Center Germantown Tennessee 38138 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Inova Schar Cancer Institute Fairfax Virginia 22031 United States Details
Next Ocology Fairfax Virginia 22031 United States Details
Fred Hutchinson Cancer Center/University of Washington Seattle Washington 98109 United States Details
Princess Margaret Cancer Center- University Health Network Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field